1. Home
  2. MNDO vs RLYB Comparison

MNDO vs RLYB Comparison

Compare MNDO & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MIND C.T.I. Ltd.

MNDO

MIND C.T.I. Ltd.

HOLD

Current Price

$1.19

Market Cap

24.2M

Sector

Technology

ML Signal

HOLD

Logo Rallybio Corporation

RLYB

Rallybio Corporation

SELL

Current Price

$10.61

Market Cap

28.7M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
MNDO
RLYB
Founded
1995
2018
Country
Israel
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.2M
28.7M
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
MNDO
RLYB
Price
$1.19
$10.61
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
N/A
AVG Volume (30 Days)
37.7K
201.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
18.33%
N/A
EPS Growth
N/A
27.72
EPS
N/A
N/A
Revenue
N/A
$600,000.00
Revenue This Year
N/A
$17.61
Revenue Next Year
N/A
N/A
P/E Ratio
$8.57
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.98
$0.22
52 Week High
$2.03
$11.20

Technical Indicators

Market Signals
Indicator
MNDO
RLYB
Relative Strength Index (RSI) 58.06 92.99
Support Level $1.13 $0.48
Resistance Level $1.24 N/A
Average True Range (ATR) 0.05 0.76
MACD 0.01 0.55
Stochastic Oscillator 80.00 89.39

Price Performance

Historical Comparison
MNDO
RLYB

About MNDO MIND C.T.I. Ltd.

MIND C.T.I. Ltd develops, manufactures, markets, and implements real-time and off-line convergent billing and customer care software solutions. It derives revenue from the sale of software products and services in two reportable segments, namely Billing and Related Services, which derives key revenue, and Messaging. The company has three product lines: Product Line A- billing and customer care solutions for service providers; Product Line B - call accounting and call management solutions for enterprises; and Product Line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in the Americas, Europe, Asia Pacific and Africa, and Israel. It earns maximum revenue from Europe.

About RLYB Rallybio Corporation

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

Share on Social Networks: